Ann-Marie Lobo

Dr. Ann-Marie Lobo

Department of Ophthalmology, University of Illinois College of Medicine, Chicago, IL 60612, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in The Ocular Surface
Verified
Journal Article
Closed access
ALAnn-Marie Lobo
Ann-Marie Lobo
AAAlex M. Agelidis
Alex M. Agelidis
DSDeepak Shukla
Deepak Shukla

10 September 2021 in Frontiers in Medicine
Verified
Journal Article
Open access
KJKatherine A. Joltikov
Katherine A. Joltikov
ALAnn-Marie Lobo
Ann-Marie Lobo
Purpose: Non-infectious uveitis is a leading cause of vision loss in the developed world. The purpose of this systematic review is to investigate the epidemiology and risk factors of non-infectious uveitis over the last 50 years.Methods: A systematic literature search of Pubmed/MEDLINE database was performed in the 50-year period from January 1971 to January 2021, according to the PRISMA guidelines. Studies that assessed the epidemiology and risk factors for non-infectious uveitis were included.Results: Few epidemiologic studies focus specifically on non-infectious uveitis. In the Unites States, the estimated prevalence of non-infectious uveitis is 121/100,000. The incidence and prevalence varies considerably worldwide. Females and the working age group (20–50 years) appear to be the most affected. Smoking and vitamin D deficiency are the biggest risk factors for non-infectious uveitis, while pregnancy appears to be protective. Additional risk factors include presence of other autoimmune diseases (thyroid disease, diabetes, celiac), pre-eclampsia/eclampsia, psychological stress, and certain medications (bisphosphonates, immune checkpoint inhibitors, female hormone therapy, and etanercept).Discussion: Our systematic review summarizes the incidence and prevalence of non-infectious uveitis and associated modifiable and non-modifiable risk factors.

28 December 2019 in Microorganisms
Verified
Journal Article
Open access
PDF file
MMMonique Munro
Monique Munro
TYTejabhiram Yadavalli
Tejabhiram Yadavalli
CFCheryl Fonteh
Cheryl Fonteh
SASafa Arfeen
Safa Arfeen
ALAnn-Marie Lobo
Ann-Marie Lobo
Cytomegalovirus retinitis (CMVR) is a severe, vision-threatening disease that primarily affects immunosuppressed patients. CMVR is the most common ocular opportunistic infection in human immunodeficiency virus (HIV) infected patients and is the leading cause of blindness in this group; however, the incidence of CMVR in HIV patients has dramatically decreased with antiretroviral therapy. Other causes of immunosuppression, including organ transplantation, hematologic malignancies, and iatrogenic immunosuppression, can also lead to the development of CMVR. Herein, we describe the pathogenesis of CMVR and compare clinical features, epidemiology, and risk factors in HIV and non-HIV infected individuals with CMVR.

18 May 2019 in Advances in Ophthalmology and Optometry
Verified
Journal Article
Closed access
JCJudy L. Chen
Judy L. Chen
PBPooja Bhat
Pooja Bhat
ALAnn-Marie Lobo
Ann-Marie Lobo

24 January 2019 in Eye
Verified
Journal Article
Closed access
PDF file
DDDana Y. Darwish
Dana Y. Darwish
SPSamir N. Patel
Samir N. Patel
YGYan Gao
Yan Gao
PBPooja Bhat
Pooja Bhat
FCFelix Y. Chau
Felix Y. Chau
ALAnn-Marie Lobo
Ann-Marie Lobo

6 October 2022 in Ophthalmic Epidemiology
Verified
Journal Article
Closed access
ALAnn-Marie Lobo
Ann-Marie Lobo
KJKatherine Joltikov
Katherine Joltikov
AHAbid Haseeb
Abid Haseeb
SMSupriya D. Mehta
Supriya D. Mehta
Uveitis is a leading cause of visual impairment and blindness.1 New therapeutic treatment options for non-infectious uveitis have improved outcomes and expanded the armamentarium of management opti...